查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1771560

大分子藥物研發外包市場規模、佔有率和趨勢分析報告：按工作流程、服務、治療領域、最終用途、地區和細分市場預測，2025 年至 2030 年

Large Molecule Drug Discovery Outsourcing Market Size, Share & Trends Analysis Report By Workflow, By Service, By Therapeutics Area, By End-use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

大分子藥物研發外包市場摘要

預計 2024 年全球大分子藥物研發外包市場規模為 28.9 億美元，到 2030 年將達到 48.3 億美元，2025 年至 2030 年的複合年成長率為 9.02%。市場受到對生技藥品和下一代療法日益成長的需求的推動。

為了滿足日益成長的生物製藥需求，製藥公司正逐漸從小分子轉向更大的生物分子化合物，例如胜肽、重組蛋白和基因修飾劑。因此，藥物申辦方正在積極尋求專門從事此類生技藥品藥物研發的委外研發機構(CRO) 的服務。這種趨勢導致了外包策略的興起，這種策略強調早期科學合作以及在生物檢測開發、結構生物學和功能篩檢等領域的專業知識。

此外，生物製藥公司與合約研究組織 (CRO) 之間的策略聯盟正成為一種新興趨勢，專注於創新的平台模式，以幫助加快資產進度並降低研發風險。此外，外包服務的需求受到科學專業知識深度、成本效益和治療領域專業化的影響。這導致與對神經退化性疾病、罕見疾病和自體免疫疾病有濃厚興趣的合作夥伴的合作需求日益增加。

此外，隨著越來越多的公司在北美和亞太等地區尋找生技藥品創新中心，全球市場的擴張正在改變生物製劑市場格局。此外，合約研究組織 (CRO) 正在整合人工智慧主導的工具、生物標記發現平台和自動化篩檢流程，以提高候選化合物選擇的準確性。科學進步、地理成長和數位創新的結合，正在將大分子發現外包確立為現代生技藥品研發策略的一個基本面向。預計這些因素將在預計期內推動市場成長。

目錄

第1章調查方法與範圍

第2章執行摘要

3. 大分子藥物研發外包市場變數、趨勢與範圍

  • 市場展望
    • 母市場展望
    • 相關/支持市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 臨床試驗數量分析（2024年）
    • 各地區臨床試驗總數
    • 各階段臨床試驗總數
    • 按研究設計分類的臨床試驗總數
    • 按主要治療領域分類的臨床試驗總數
  • 定價模式分析
  • 技術格局
  • 市場分析工具
    • 波特五力分析
    • PESTEL 與 SWOT 分析
    • COVID-19影響分析

第4章大分子藥物研發外包市場：工作流程評估與趨勢分析

  • 大分子藥物研發外包市場（依工作流程）：細分儀表板
  • 大分子藥物研發外包市場（依工作流程）：差異分析
  • 按工作流程，2018-2030
  • 目標識別與篩檢
  • 目標檢驗和功能資訊科學
  • 潛在客戶資格審查和候選人最佳化
  • 臨床前開發
  • 其他

第5章大分子藥物研發外包市場：服務評估與趨勢分析

  • 大分子藥物研發外包市場（按服務）：細分儀表板
  • 大分子藥物研發外包市場（按服務）：波動分析
  • 按服務分類，2018-2030 年
  • 化學服務
  • 生物服務

第6章大分子藥物研發外包市場：治療藥物領域的估價與趨勢分析

  • 大分子藥物研發外包市場（依治療領域）：細分儀表板
  • 大分子藥物研發外包市場（依治療領域）：波動分析
  • 依治療領域，2018-2030年
  • 呼吸系統
  • 疼痛和麻醉
  • 腫瘤學
  • 眼科
  • 血液學
  • 心血管系統
  • 內分泌
  • 胃腸道
  • 免疫調節
  • 抗感染
  • 中樞神經系統
  • 皮膚科
  • 泌尿生殖系統

第7章大分子藥物發現外包市場：最終用途估計與趨勢分析

  • 大分子藥物研發外包市場（依最終用途）：細分儀表板
  • 大分子藥物研發外包市場（依最終用途）：差異分析
  • 按應用，2018-2030 年
  • 製藥和生物技術公司
  • 學術機構

第8章大分子藥物發現外包市場：區域估計與趨勢分析

  • 區域市場儀表板
  • 2024 年及 2030 年區域市場佔有率分析
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 泰國
    • 韓國
    • 澳洲
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第9章 競爭態勢

  • 市場參與企業分類
  • 2024 年公司市場佔有率/估值分析
  • 公司簡介
    • Evotec SE
    • Charles River Laboratories International, Inc.
    • WuXi AppTec
    • Laboratory Corporation of America Holdings
    • Thermo Fisher Scientific Inc.
    • Merck &Co., Inc.
    • GenScript Biotech Corporation
    • Jubilant Biosys Limited
    • Pharmaron Beijing Co., Ltd.
    • Syngene International Limited
    • Dalton Pharma Services
    • Domainex Ltd.
    • Eurofins Scientific SE
    • QIAGEN NV
    • TCG Lifesciences Pvt Ltd.
Product Code: GVR-4-68040-616-6

Large Molecule Drug Discovery Outsourcing Market Summary

The global large molecule drug discovery outsourcing market size was estimated at USD 2.89 billion in 2024 and is projected to reach USD 4.83 billion by 2030, growing at a CAGR of 9.02% from 2025 to 2030. The market is driven by increased demand for biologics and next-generation therapies.

Pharmaceutical companies are increasingly shifting their focus from small molecules to larger biomolecules, including peptides, recombinant proteins, and gene-modifying agents, due to rising demand for biologics. As a result, drug sponsors are actively seeking the services of contract research organizations (CROs) that specialize in drug discovery tailored to these biologics. This trend has led to a rise in outsourcing strategies that emphasize early-phase scientific collaboration and expertise in areas such as bioassay development, structural biology, and functional screening.

Furthermore, emerging trends highlight strategic partnerships between biopharma companies and CROs that focus on innovative platform-based models, which serve to mitigate R&D risks while enhancing the progression of assets. In addition, the demand for outsourcing services is more influenced by the depth of scientific expertise, cost effectiveness, and specialization in therapeutic areas. This has led increasing demand for collaboration with partners who have a strong focus on neurodegenerative diseases, rare disorders, and autoimmune conditions.

Moreover, the global expansion of the market is transforming the landscape, as companies seek biologics innovation hubs in regions like North America and Asia Pacific. In addition, CROs are integrating AI-driven tools, biomarker discovery platforms, and automated screening processes to enhance the accuracy of candidate selection. This combination of scientific advancement, geographical growth, and digital innovation is establishing large molecule discovery outsourcing as a fundamental aspect of modern biologics R&D strategies. Such factors are expected to drive market growth over the estimated time period.

Global Large Molecule Drug Discovery Outsourcing Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global large molecule drug discovery outsourcing market report based on workflow, service, therapeutics area, end-use, and region:

  • Workflow Outlook (Revenue, USD Million, 2018 - 2030)
  • Target Identification & Screening
  • Target Validation & Functional Informatics
  • Lead Identification & Candidate Optimization
  • Preclinical Development
  • Others
  • Service Outlook (Revenue, USD Million, 2018 - 2030)
  • Chemistry Services
  • Biology Services
  • Therapeutics Area Outlook (Revenue, USD Million, 2018 - 2030)
  • Respiratory system
  • Pain and Anesthesia
  • Oncology
  • Ophthalmology
  • Hematology
  • Cardiovascular
  • Endocrine
  • Gastrointestinal
  • Immunomodulation
  • Anti-infective
  • Central Nervous System
  • Dermatology
  • Genitourinary System
  • End-use Outlook (Revenue, USD Million, 2018 - 2030)
  • Pharmaceutical & Biotechnology companies
  • Academic Institutes
  • Regional Outlook (Revenue, USD Million, 2018 - 2030)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Sweden
    • Denmark
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Thailand
    • South Korea
    • Australia
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • Argentina
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Research Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Workflow
    • 1.2.2. Service
    • 1.2.3. Therapeutics Area
    • 1.2.4. End Use
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
    • 1.4.3. Secondary Sources
    • 1.4.4. Primary Research
  • 1.5. Information Or Data Analysis
    • 1.5.1. Data Analysis Models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity Flow Analysis
    • 1.7.2. Parent Market Analysis
  • 1.8. List Of Secondary Sources
  • 1.9. List Of Abbreviations
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Large Molecule Drug Discovery Outsourcing Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Clinical Trials Volume Analysis, (2024)
    • 3.3.1. Total Number Of Clinical Trials By Region
    • 3.3.2. Total Number Of Clinical Trials, By Phase
    • 3.3.3. Total Number Of Clinical Trials, By Study Design
    • 3.3.4. Total Number Of Clinical Trials, By Key Therapeutic Area
  • 3.4. Pricing Model Analysis
  • 3.5. Technology Landscape
  • 3.6. Market Analysis Tools
    • 3.6.1. Porter's Five Force Analysis
    • 3.6.2. PESTEL by SWOT Analysis
    • 3.6.3. COVID-19 Impact Analysis

Chapter 4. Large Molecule Drug Discovery Outsourcing Market: Workflow Estimates & Trend Analysis

  • 4.1. Large Molecule Drug Discovery Outsourcing Market, By Workflow: Segment Dashboard
  • 4.2. Large Molecule Drug Discovery Outsourcing Market, By Workflow: Movement Analysis
  • 4.3. Large Molecule Drug Discovery Outsourcing Market Estimates & Forecasts, By Workflow, 2018 - 2030 (USD Million)
  • 4.4. Target Identification & Screening
    • 4.4.1. Target Identification & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Target Validation & Functional Informatics
    • 4.5.1. Target Validation & Functional Informatics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. Lead Identification & Candidate Optimization
    • 4.6.1. Lead Identification & Candidate Optimization Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.7. Preclinical Development
    • 4.7.1. Preclinical Development Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.8. Others
    • 4.8.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Large Molecule Drug Discovery Outsourcing Market: Service Estimates & Trend Analysis

  • 5.1. Large Molecule Drug Discovery Outsourcing Market, By Service: Segment Dashboard
  • 5.2. Large Molecule Drug Discovery Outsourcing Market, By Service: Movement Analysis
  • 5.3. Large Molecule Drug Discovery Outsourcing Market Estimates & Forecasts, By Service, 2018 - 2030 (USD Million)
  • 5.4. Chemistry Services
    • 5.4.1. Chemistry Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Biology Services
    • 5.5.1. Biology Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Large Molecule Drug Discovery Outsourcing Market: Therapeutics Area Estimates & Trend Analysis

  • 6.1. Large Molecule Drug Discovery Outsourcing Market, By Therapeutics Area: Segment Dashboard
  • 6.2. Large Molecule Drug Discovery Outsourcing Market, By Therapeutics Area: Movement Analysis
  • 6.3. Large Molecule Drug Discovery Outsourcing Market Estimates & Forecasts, By Therapeutics Area, 2018 - 2030 (USD Million)
  • 6.4. Respiratory system
    • 6.4.1. Respiratory System Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Pain and Anesthesia
    • 6.5.1. Pain and Anesthesia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Oncology
    • 6.6.1. Oncology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.7. Ophthalmology
    • 6.7.1. Ophthalmology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.8. Hematology
    • 6.8.1. Hematology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.9. Cardiovascular
    • 6.9.1. Cardiovascular Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.10. Endocrine
    • 6.10.1. Endocrine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.11. Gastrointestinal
    • 6.11.1. Gastrointestinal Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.12. Immunomodulation
    • 6.12.1. Immunomodulation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.13. Anti-infective
    • 6.13.1. Anti-infective Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.14. Central Nervous System
    • 6.14.1. Central Nervous System Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.15. Dermatology
    • 6.15.1. Dermatology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.16. Genitourinary System
    • 6.16.1. Genitourinary System Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Large Molecule Drug Discovery Outsourcing Market: End Use Estimates & Trend Analysis

  • 7.1. Large Molecule Drug Discovery Outsourcing Market, By End Use: Segment Dashboard
  • 7.2. Large Molecule Drug Discovery Outsourcing Market, By End Use: Movement Analysis
  • 7.3. Large Molecule Drug Discovery Outsourcing Market Estimates & Forecasts, By End Use, 2018 - 2030 (USD Million)
  • 7.4. Pharmaceutical & Biotechnology companies
    • 7.4.1. Pharmaceutical & Biotechnology companies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Academic Institutes
    • 7.5.1. Academic Institutes Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Large Molecule Drug Discovery Outsourcing Market: Regional Estimates & Trend Analysis

  • 8.1. Regional Market Dashboard
  • 8.2. Regional Market Share Analysis, 2024 & 2030
  • 8.3. North America
    • 8.3.1. North America Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.2. U.S
      • 8.3.2.1. Key Country Dynamics
      • 8.3.2.2. Competitive Scenario
      • 8.3.2.3. Regulatory Framework
      • 8.3.2.4. U.S. Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.3. Canada
      • 8.3.3.1. Key Country Dynamics
      • 8.3.3.2. Competitive Scenario
      • 8.3.3.3. Regulatory Framework
      • 8.3.3.4. Canada Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.4. Mexico
      • 8.3.4.1. Key Country Dynamics
      • 8.3.4.2. Competitive Scenario
      • 8.3.4.3. Regulatory Framework
      • 8.3.4.4. Mexico Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.4. Europe
    • 8.4.1. Europe Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.2. UK
      • 8.4.2.1. Key Country Dynamics
      • 8.4.2.2. Competitive Scenario
      • 8.4.2.3. Regulatory Framework
      • 8.4.2.4. UK Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.3. Germany
      • 8.4.3.1. Key Country Dynamics
      • 8.4.3.2. Competitive Scenario
      • 8.4.3.3. Regulatory Framework
      • 8.4.3.4. Germany Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.4. France
      • 8.4.4.1. Key Country Dynamics
      • 8.4.4.2. Competitive Scenario
      • 8.4.4.3. Regulatory Framework
      • 8.4.4.4. France Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.5. Italy
      • 8.4.5.1. Key Country Dynamics
      • 8.4.5.2. Competitive Scenario
      • 8.4.5.3. Regulatory Framework
      • 8.4.5.4. Italy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.6. Spain
      • 8.4.6.1. Key Country Dynamics
      • 8.4.6.2. Competitive Scenario
      • 8.4.6.3. Regulatory Framework
      • 8.4.6.4. Spain Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.7. Denmark
      • 8.4.7.1. Key Country Dynamics
      • 8.4.7.2. Competitive Scenario
      • 8.4.7.3. Regulatory Framework
      • 8.4.7.4. Denmark Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.8. Sweden
      • 8.4.8.1. Key Country Dynamics
      • 8.4.8.2. Competitive Scenario
      • 8.4.8.3. Regulatory Framework
      • 8.4.8.4. Sweden Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.9. Norway
      • 8.4.9.1. Key Country Dynamics
      • 8.4.9.2. Competitive Scenario
      • 8.4.9.3. Regulatory Framework
      • 8.4.9.4. Norway Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5. Asia Pacific
    • 8.5.1. Asia Pacific Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.2. Japan
      • 8.5.2.1. Key Country Dynamics
      • 8.5.2.2. Competitive Scenario
      • 8.5.2.3. Regulatory Framework
      • 8.5.2.4. Japan Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.3. China
      • 8.5.3.1. Key Country Dynamics
      • 8.5.3.2. Competitive Scenario
      • 8.5.3.3. Regulatory Framework
      • 8.5.3.4. China Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.4. India
      • 8.5.4.1. Key Country Dynamics
      • 8.5.4.2. Competitive Scenario
      • 8.5.4.3. Regulatory Framework
      • 8.5.4.4. India Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.5. Thailand
      • 8.5.5.1. Key Country Dynamics
      • 8.5.5.2. Competitive Scenario
      • 8.5.5.3. Regulatory Framework
      • 8.5.5.4. Thailand Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.6. South Korea
      • 8.5.6.1. Key Country Dynamics
      • 8.5.6.2. Competitive Scenario
      • 8.5.6.3. Regulatory Framework
      • 8.5.6.4. South Korea Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.7. Australia
      • 8.5.7.1. Key Country Dynamics
      • 8.5.7.2. Competitive Scenario
      • 8.5.7.3. Regulatory Framework
      • 8.5.7.4. Australia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6. Latin America
    • 8.6.1. Latin America Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.2. Brazil
      • 8.6.2.1. Key Country Dynamics
      • 8.6.2.2. Competitive Scenario
      • 8.6.2.3. Regulatory Framework
      • 8.6.2.4. Brazil Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.3. Argentina
      • 8.6.3.1. Key Country Dynamics
      • 8.6.3.2. Competitive Scenario
      • 8.6.3.3. Regulatory Framework
      • 8.6.3.4. Argentina Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.7. MEA
    • 8.7.1. MEA Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.7.2. South Africa
      • 8.7.2.1. Key Country Dynamics
      • 8.7.2.2. Competitive Scenario
      • 8.7.2.3. Regulatory Framework
      • 8.7.2.4. South Africa Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.7.3. Saudi Arabia
      • 8.7.3.1. Key Country Dynamics
      • 8.7.3.2. Competitive Scenario
      • 8.7.3.3. Regulatory Framework
      • 8.7.3.4. Saudi Arabia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.7.4. UAE
      • 8.7.4.1. Key Country Dynamics
      • 8.7.4.2. Competitive Scenario
      • 8.7.4.3. Regulatory Framework
      • 8.7.4.4. UAE Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.7.5. Kuwait
      • 8.7.5.1. Key Country Dynamics
      • 8.7.5.2. Competitive Scenario
      • 8.7.5.3. Regulatory Framework
      • 8.7.5.4. Kuwait Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Market Participant Categorization
  • 9.2. Company Market Share/Assessment Analysis, 2024
  • 9.3. Company Profiles
    • 9.3.1. Evotec SE
      • 9.3.1.1. Company Overview
      • 9.3.1.2. Financial Performance
      • 9.3.1.3. Service Benchmarking
      • 9.3.1.4. Strategic Initiatives
    • 9.3.2. Charles River Laboratories International, Inc.
      • 9.3.2.1. Company Overview
      • 9.3.2.2. Financial Performance
      • 9.3.2.3. Service Benchmarking
      • 9.3.2.4. Strategic Initiatives
    • 9.3.3. WuXi AppTec
      • 9.3.3.1. Company Overview
      • 9.3.3.2. Financial Performance
      • 9.3.3.3. Service Benchmarking
      • 9.3.3.4. Strategic Initiatives
    • 9.3.4. Laboratory Corporation of America Holdings
      • 9.3.4.1. Company Overview
      • 9.3.4.2. Financial Performance
      • 9.3.4.3. Service Benchmarking
      • 9.3.4.4. Strategic Initiatives
    • 9.3.5. Thermo Fisher Scientific Inc.
      • 9.3.5.1. Company Overview
      • 9.3.5.2. Financial Performance
      • 9.3.5.3. Service Benchmarking
      • 9.3.5.4. Strategic Initiatives
    • 9.3.6. Merck & Co., Inc.
      • 9.3.6.1. Company Overview
      • 9.3.6.2. Financial Performance
      • 9.3.6.3. Service Benchmarking
      • 9.3.6.4. Strategic Initiatives
    • 9.3.7. GenScript Biotech Corporation
      • 9.3.7.1. Company Overview
      • 9.3.7.2. Financial Performance
      • 9.3.7.3. Service Benchmarking
      • 9.3.7.4. Strategic Initiatives
    • 9.3.8. Jubilant Biosys Limited
      • 9.3.8.1. Company Overview
      • 9.3.8.2. Financial Performance
      • 9.3.8.3. Service Benchmarking
      • 9.3.8.4. Strategic Initiatives
    • 9.3.9. Pharmaron Beijing Co., Ltd.
      • 9.3.9.1. Company Overview
      • 9.3.9.2. Financial Performance
      • 9.3.9.3. Service Benchmarking
      • 9.3.9.4. Strategic Initiatives
    • 9.3.10. Syngene International Limited
      • 9.3.10.1. Company Overview
      • 9.3.10.2. Financial Performance
      • 9.3.10.3. Service Benchmarking
      • 9.3.10.4. Strategic Initiatives
    • 9.3.11. Dalton Pharma Services
      • 9.3.11.1. Company Overview
      • 9.3.11.2. Financial Performance
      • 9.3.11.3. Service Benchmarking
      • 9.3.11.4. Strategic Initiatives
    • 9.3.12. Domainex Ltd.
      • 9.3.12.1. Company Overview
      • 9.3.12.2. Financial Performance
      • 9.3.12.3. Service Benchmarking
      • 9.3.12.4. Strategic Initiatives
    • 9.3.13. Eurofins Scientific SE
      • 9.3.13.1. Company Overview
      • 9.3.13.2. Financial Performance
      • 9.3.13.3. Service Benchmarking
      • 9.3.13.4. Strategic Initiatives
    • 9.3.14. QIAGEN N.V.
      • 9.3.14.1. Company Overview
      • 9.3.14.2. Financial Performance
      • 9.3.14.3. Service Benchmarking
      • 9.3.14.4. Strategic Initiatives
    • 9.3.15. TCG Lifesciences Pvt Ltd.
      • 9.3.15.1. Company Overview
      • 9.3.15.2. Financial Performance
      • 9.3.15.3. Service Benchmarking
      • 9.3.15.4. Strategic Initiatives

List of Tables

  • Table 1. List of Secondary Sources
  • Table 2. List of Abbreviations
  • Table 3. Global Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2018 - 2030 (USD Million)
  • Table 4. Global Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 5. Global Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2018 - 2030 (USD Million)
  • Table 6. Global Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 7. Global Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Region, 2018 - 2030 (USD Million)
  • Table 8. North America Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
  • Table 9. North America Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2018 - 2030 (USD Million)
  • Table 10. North America Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 11. North America Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2018 - 2030 (USD Million)
  • Table 12. North America Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 13. U.S. Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2018 - 2030 (USD Million)
  • Table 14. U.S. Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 15. U.S. Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2018 - 2030 (USD Million)
  • Table 16. U.S. Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 17. Canada Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2018 - 2030 (USD Million)
  • Table 18. Canada Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 19. Canada Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2018 - 2030 (USD Million)
  • Table 20. Canada Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 21. Mexico Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2018 - 2030 (USD Million)
  • Table 22. Mexico Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 23. Mexico Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2018 - 2030 (USD Million)
  • Table 24. Mexico Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 25. Europe Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
  • Table 26. Europe Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2018 - 2030 (USD Million)
  • Table 27. Europe Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 28. Europe Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2018 - 2030 (USD Million)
  • Table 29. Europe Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 30. UK Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2018 - 2030 (USD Million)
  • Table 31. UK Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 32. UK Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2018 - 2030 (USD Million)
  • Table 33. UK Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 34. Germany Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2018 - 2030 (USD Million)
  • Table 35. Germany Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 36. Germany Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2018 - 2030 (USD Million)
  • Table 37. Germany Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 38. France Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2018 - 2030 (USD Million)
  • Table 39. France Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 40. France Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2018 - 2030 (USD Million)
  • Table 41. France Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 42. Italy Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2018 - 2030 (USD Million)
  • Table 43. Italy Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 44. Italy Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2018 - 2030 (USD Million)
  • Table 45. Italy Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 46. Spain Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2018 - 2030 (USD Million)
  • Table 47. Spain Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 48. Spain Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2018 - 2030 (USD Million)
  • Table 49. Spain Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 50. Denmark Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2018 - 2030 (USD Million)
  • Table 51. Denmark Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 52. Denmark Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2018 - 2030 (USD Million)
  • Table 53. Denmark Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 54. Sweden Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2018 - 2030 (USD Million)
  • Table 55. Sweden Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 56. Sweden Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2018 - 2030 (USD Million)
  • Table 57. Sweden Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 58. Norway Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2018 - 2030 (USD Million)
  • Table 59. Norway Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 60. Norway Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2018 - 2030 (USD Million)
  • Table 61. Norway Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 62. Asia Pacific Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
  • Table 63. Asia Pacific Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2018 - 2030 (USD Million)
  • Table 64. Asia Pacific Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 65. Asia Pacific Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2018 - 2030 (USD Million)
  • Table 66. Asia Pacific Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 67. Japan Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2018 - 2030 (USD Million)
  • Table 68. Japan Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 69. Japan Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2018 - 2030 (USD Million)
  • Table 70. Japan Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 71. China Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2018 - 2030 (USD Million)
  • Table 72. China Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 73. China Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2018 - 2030 (USD Million)
  • Table 74. China Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 75. India Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2018 - 2030 (USD Million)
  • Table 76. India Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 77. India Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2018 - 2030 (USD Million)
  • Table 78. India Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 79. Thailand Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2018 - 2030 (USD Million)
  • Table 80. Thailand Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 81. Thailand Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2018 - 2030 (USD Million)
  • Table 82. Thailand Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 83. South Korea Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2018 - 2030 (USD Million)
  • Table 84. South Korea Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 85. South Korea Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2018 - 2030 (USD Million)
  • Table 86. South Korea Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 87. Australia Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2018 - 2030 (USD Million)
  • Table 88. Australia Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 89. Australia Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2018 - 2030 (USD Million)
  • Table 90. Australia Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 91. Latin America Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
  • Table 92. Latin America Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2018 - 2030 (USD Million)
  • Table 93. Latin America Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 94. Latin America Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2018 - 2030 (USD Million)
  • Table 95. Latin America Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 96. Brazil Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2018 - 2030 (USD Million)
  • Table 97. Brazil Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 98. Brazil Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2018 - 2030 (USD Million)
  • Table 99. Brazil Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 100. Argentina Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2018 - 2030 (USD Million)
  • Table 101. Argentina Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 102. Argentina Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2018 - 2030 (USD Million)
  • Table 103. Argentina Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 104. Middle East & Africa Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
  • Table 105. Middle East & Africa Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2018 - 2030 (USD Million)
  • Table 106. Middle East & Africa Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 107. Middle East & Africa Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2018 - 2030 (USD Million)
  • Table 108. Middle East & Africa Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 109. South Africa Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2018 - 2030 (USD Million)
  • Table 110. South Africa Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 111. South Africa Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2018 - 2030 (USD Million)
  • Table 112. South Africa Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 113. Saudi Arabia Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2018 - 2030 (USD Million)
  • Table 114. Saudi Arabia Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 115. Saudi Arabia Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2018 - 2030 (USD Million)
  • Table 116. Saudi Arabia Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 117. UAE Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2018 - 2030 (USD Million)
  • Table 118. UAE Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 119. UAE Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2018 - 2030 (USD Million)
  • Table 120.UAE Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 121. Kuwait Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2018 - 2030 (USD Million)
  • Table 122. Kuwait Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 123. Kuwait Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2018 - 2030 (USD Million)
  • Table 124. Kuwait Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Market formulation & validation
  • Fig. 6 Commodity flow analysis
  • Fig. 7 Value-chain-based sizing & forecasting
  • Fig. 8 QFD model sizing & forecasting
  • Fig. 9 Bottom-up approach
  • Fig. 10 Market snapshot
  • Fig. 11 Segment snapshot 1
  • Fig. 12 Segment snapshot 2
  • Fig. 13 Competitive landscape snapshot
  • Fig. 14 Parent market outlook, 2024 (USD Billion)
  • Fig. 15 Ancillary market outlook, 2024 (USD Billion)
  • Fig. 16 Large Molecule Drug Discovery Outsourcing Market Dynamics
  • Fig. 17 Porter's five forces analysis
  • Fig. 18 PESTEL analysis
  • Fig. 19 Large Molecule Drug Discovery Outsourcing Market: Workflow outlook and key takeaways
  • Fig. 20 Large Molecule Drug Discovery Outsourcing Market: Workflow movement analysis
  • Fig. 21 Target Identification & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 Target Validation & Functional Informatics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 Lead Identification & Candidate Optimization Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 24 Preclinical Development Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 Other Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Large Molecule Drug Discovery Outsourcing Market: Service outlook and key takeaways
  • Fig. 27 Large Molecule Drug Discovery Outsourcing Market: Service movement analysis
  • Fig. 28 Chemistry Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 Biology Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Large Molecule Drug Discovery Outsourcing Market: Therapeutics Area outlook and key takeaways
  • Fig. 31 Large Molecule Drug Discovery Outsourcing Market: Therapeutics Area movement analysis
  • Fig. 32 Respiratory system Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Pain and Anesthesia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Oncology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Ophthalmology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Hematology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Cardiovascular Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Endocrine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Gastrointestinal Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Immunomodulation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Anti-infective Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Central Nervous System Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Dermatology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Genitourinary System Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Large Molecule Drug Discovery Outsourcing Market: End Use outlook and key takeaways
  • Fig. 46 Large Molecule Drug Discovery Outsourcing Market: End Use movement analysis
  • Fig. 47 Pharmaceutical & Biotechnology companies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Academic Institutes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Regional Marketplace: Key Takeaways
  • Fig. 50 North America Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Key country dynamics
  • Fig. 52 U.S. Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Key country dynamics
  • Fig. 54 Canada Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Key country dynamics
  • Fig. 56 Mexico Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Europe Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 Key country dynamics
  • Fig. 59 UK Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 Key country dynamics
  • Fig. 61 Germany Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 Key country dynamics
  • Fig. 63 France Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 64 Key country dynamics
  • Fig. 65 Italy Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 66 Key country dynamics
  • Fig. 67 Spain Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 68 Key country dynamics
  • Fig. 69 Denmark Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 70 Key country dynamics
  • Fig. 71 Sweden Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 72 Key country dynamics
  • Fig. 73 Norway Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 74 Asia Pacific Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 75 Key country dynamics
  • Fig. 76 Japan Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 77 Key country dynamics
  • Fig. 78 China Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 79 Key country dynamics
  • Fig. 80 India Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 81 Key country dynamics
  • Fig. 82 Thailand Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 83 Key country dynamics
  • Fig. 84 South Korea Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 85 Key country dynamics
  • Fig. 86 Australia Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 87 Latin America Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 88 Key country dynamics
  • Fig. 89 Brazil Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 90 Key country dynamics
  • Fig. 91 Argentina Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 92 MEA Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 93 Key country dynamics
  • Fig. 94 South Africa Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 95 Key country dynamics
  • Fig. 96 Saudi Arabia Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 97 Key country dynamics
  • Fig. 98 UAE Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 99 Key country dynamics
  • Fig. 100 Kuwait Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 101 Key company categorization
  • Fig. 102 Service heat map analysis
  • Fig. 103 Strategic framework